Moderna to Present at Upcoming Conferences in June 2025
Moderna (NASDAQ: MRNA) has announced its upcoming participation in two major investor conferences in June 2025. The company will present at the Jefferies Global Health Care Conference on June 5th at 10:30am ET and the Goldman Sachs 46th Annual Global Healthcare Conference on June 11th at 8:40am ET.
Live webcasts of both presentations will be accessible through the "Events and Presentations" section on Moderna's investor website. Replays will remain available for at least 30 days after each presentation.
Moderna (NASDAQ: MRNA) ha annunciato la sua partecipazione a due importanti conferenze per investitori previste per giugno 2025. L'azienda presenterà al Jefferies Global Health Care Conference il 5 giugno alle 10:30 ET e al Goldman Sachs 46th Annual Global Healthcare Conference l'11 giugno alle 8:40 ET.
Le dirette streaming di entrambe le presentazioni saranno disponibili nella sezione "Eventi e Presentazioni" del sito web per investitori di Moderna. Le registrazioni resteranno accessibili per almeno 30 giorni dopo ogni presentazione.
Moderna (NASDAQ: MRNA) ha anunciado su próxima participación en dos importantes conferencias para inversores en junio de 2025. La compañía presentará en la Jefferies Global Health Care Conference el 5 de junio a las 10:30 am ET y en la Goldman Sachs 46th Annual Global Healthcare Conference el 11 de junio a las 8:40 am ET.
Las transmisiones en vivo de ambas presentaciones estarán disponibles en la sección "Eventos y Presentaciones" del sitio web para inversores de Moderna. Las repeticiones estarán accesibles por al menos 30 días después de cada presentación.
모더나 (NASDAQ: MRNA)는 2025년 6월에 열리는 두 개의 주요 투자자 컨퍼런스에 참가할 예정임을 발표했습니다. 회사는 6월 5일 오전 10시 30분(동부시간)에 Jefferies Global Health Care Conference에서, 6월 11일 오전 8시 40분(동부시간)에 Goldman Sachs 46th Annual Global Healthcare Conference에서 발표할 예정입니다.
두 발표 모두 모더나 투자자 웹사이트의 "이벤트 및 프레젠테이션" 섹션을 통해 생중계되며, 각 발표 후 최소 30일간 다시보기 서비스를 제공합니다.
Moderna (NASDAQ : MRNA) a annoncé sa participation prochaine à deux grandes conférences pour investisseurs en juin 2025. La société présentera lors de la Jefferies Global Health Care Conference le 5 juin à 10h30 ET et lors de la Goldman Sachs 46th Annual Global Healthcare Conference le 11 juin à 8h40 ET.
Les webdiffusions en direct des deux présentations seront accessibles dans la section « Événements et Présentations » du site investisseur de Moderna. Les rediffusions resteront disponibles pendant au moins 30 jours après chaque présentation.
Moderna (NASDAQ: MRNA) hat seine bevorstehende Teilnahme an zwei wichtigen Investorenkonferenzen im Juni 2025 angekündigt. Das Unternehmen wird am Jefferies Global Health Care Conference am 5. Juni um 10:30 Uhr ET und am Goldman Sachs 46th Annual Global Healthcare Conference am 11. Juni um 8:40 Uhr ET präsentieren.
Live-Webcasts beider Präsentationen sind über den Bereich „Events and Presentations“ auf der Investorenseite von Moderna zugänglich. Aufzeichnungen sind mindestens 30 Tage nach jeder Präsentation verfügbar.
- None.
- None.
CAMBRIDGE, MA / ACCESS Newswire / May 27, 2025 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences:
Jefferies Global Health Care Conference, on Thursday, June 5th at 10:30am ET
Goldman Sachs 46th Annual Global Healthcare Conference, on Wednesday, June 11th at 8:40am ET
A live webcast of each of these presentations will be available under "Events and Presentations" in the Investors section of the Moderna website.
A replay of each webcast will be archived on Moderna's website for at least 30 days following the presentation.
About Moderna
Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.
Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.
Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
Lavina.Talukdar@modernatx.com
SOURCE: Moderna, Inc.
View the original press release on ACCESS Newswire
FAQ
When is Moderna presenting at the Jefferies Global Health Care Conference in June 2025?
What time is Moderna's presentation at the Goldman Sachs Healthcare Conference in June 2025?
How long will Moderna's June 2025 conference presentation webcasts be available for replay?
Where can I watch Moderna's investor conference presentations in June 2025?
